Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04394754 · ClinicalTrials.gov registry record · NA
Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 182
- Enrollment target
NCT04394754 is a NA study that has completed, run by Yale University. The registered enrollment target is 182 participants.
The verdict
NCT04394754, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 182 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of three novel digital health technologies versus usual care in the management of congestive heart failure, as assessed by a primary outcome of improvement in quality of life, and a variety of secondary outcomes that include metrics measuring patient and provider satisfaction, clinical efficiency, and patient outcomes.
Interventions
- DEVICE BodyPort
- OTHER Noom
- OTHER Conversa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 182 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04394754
The ClinicalTrials.gov registry entry for NCT04394754 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which BodyPort is the first listed.
NCT04394754 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04394754 about?
NCT04394754 is a clinical study titled "Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure". The purpose of this study is to determine the efficacy of three novel digital health technologies versus usual care in the management of congestive heart failure, as assessed by a primary outcome of improvement in quality of life, and a variety of secondary outcomes that include metrics measuring pa...
What is the current status of trial NCT04394754?
This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2020-09-21. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT04394754?
The interventions under investigation include: BodyPort (DEVICE), Noom (OTHER), Conversa (OTHER).
Who is sponsoring clinical trial NCT04394754?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.